Is risk-based clinical trial monitoring too flexible for the regulators? from Outsourcing-Pharma Podcast

Is risk-based clinical trial monitoring too flexible for the regulators?

4 minutes Posted Nov 12, 2012 at 12:00 am.

0:00

4:34

Share at current time

Show notes

Risk-based monitoring for clinical trials was a hot topic at this year’s PCT Europe thanks to recent draft guidances from the FDA and the EMA.